Cargando…
TERT Promoter Alterations in Glioblastoma: A Systematic Review
SIMPLE SUMMARY: Glioblastoma is the most common malignant primary brain tumor in adults. Glioblastoma accounts for 2 to 3 cases per 100,000 persons in North America and Europe. Glioblastoma classification is now based on histopathological and molecular features including isocitrate dehydrogenase (ID...
Autores principales: | Olympios, Nathalie, Gilard, Vianney, Marguet, Florent, Clatot, Florian, Di Fiore, Frédéric, Fontanilles, Maxime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962450/ https://www.ncbi.nlm.nih.gov/pubmed/33800183 http://dx.doi.org/10.3390/cancers13051147 |
Ejemplares similares
-
Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma
por: Fontanilles, Maxime, et al.
Publicado: (2020) -
Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy
por: Lambertini, Matteo, et al.
Publicado: (2019) -
Integrative Metabolomics Reveals Deep Tissue and Systemic Metabolic Remodeling in Glioblastoma
por: Gilard, Vianney, et al.
Publicado: (2021) -
Diagnosis and Management of Glioblastoma: A Comprehensive Perspective
por: Gilard, Vianney, et al.
Publicado: (2021) -
Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma
por: Fontanilles, Maxime, et al.
Publicado: (2020)